Latest #Dana Farber Cancer Institute News
Pancreatic Cancer Trial Finds Daraxonrasib Doubled Survival Time
A trial of daraxonrasib doubled survival in advanced pancreatic cancer, with fewer si...
#Dana Farber Cancer Institute
1
Posts